1) Hobbs HE, et al : Retinopathy following chloroquine therapy. Lancet 1959 ; 2 : 478-480.
2) Ahn SJ, et al : Optical Coherence Tomography Protocols for Screening of Hydroxychloroquine Retinopathy in Asian Patients. Am J Ophthalmol 2017 ; 184 : 11-18.
3) Browning DJ, et al : Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines. Am J Ophthalmol 2020 ; 219 : 101-106.
4) Jorge A, et al : Hydroxychloroquine retinopathy-implications of research advances for rheumatology care. Nat Rev Rheumatol 2018 ; 14 : 693-703.
5) Marmor MF, et al : Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 2011 ; 118 : 415-422.
6) Marmor MF, et al : Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology 2016 ; 123 : 1386-1394.
7) 近藤峰生ら : ヒドロキシクロロキン適正使用のための手引き. 日本眼科学会雑誌 2016 ; 120 : 419-428.
8) Tsang AC, et al : The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity. Am J Ophthalmol 2019 ; 206 : 132-139.
9) Ahn SJ, et al : TOXIC EFFECTS OF HYDROXYCHLOROQUINE ON THE CHOROID : Evidence From Multimodal Imaging. Retina 2019 ; 39 : 1016-1026.
10) Ahn SJ, et al : Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence : Peripheral Findings in the Retinopathy. Am J Ophthalmol 2020 ; 209 : 35-44.
11) Kim KE, et al : Use of Optical Coherence Tomography Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening. Ophthalmology 2020. pii : S0161-6420 (20) 30562-5.
12) Lee DH, et al : Pericentral hydroxychloroquine retinopathy in Korean patients. Ophthalmology 2015 ; 122 : 1252-1256.
13) Melles RB, et al : Pericentral retinopathy and racial differences in hydroxychloroquine toxicity. Ophthalmology 2015 ; 122 : 110-116.